Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Operations (2019 - 2026)

BioScience Health Innovations has reported Cash from Operations over the past 8 years, most recently at 552107.0 for Q1 2026.

  • Quarterly Cash from Operations fell 268.17% to 552107.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 708238.0 through Mar 2026, down 277.26% year-over-year, with the annual reading at 172178.0 for FY2025, 642.53% up from the prior year.
  • Cash from Operations was 552107.0 for Q1 2026 at BioScience Health Innovations, down from 100696.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 328309.0 in Q1 2025 and troughed at 552107.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 50305.0 (2024), against an average of 47834.67.
  • The largest YoY upside for Cash from Operations was 783.41% in 2025 against a maximum downside of 751.78% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 27910.0 in 2022, then plummeted by 102.28% to 56457.0 in 2023, then increased by 10.9% to 50305.0 in 2024, then tumbled by 100.17% to 100696.0 in 2025, then plummeted by 448.29% to 552107.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Cash from Operations are 552107.0 (Q1 2026), 100696.0 (Q4 2025), and 340445.0 (Q3 2025).